Premium
Lithium and sexual dysfunction: an under‐researched area
Author(s) -
Elnazer Hesham Y.,
Sampson Anthony,
Baldwin David
Publication year - 2015
Publication title -
human psychopharmacology: clinical and experimental
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.461
H-Index - 78
eISSN - 1099-1077
pISSN - 0885-6222
DOI - 10.1002/hup.2457
Subject(s) - lithium (medication) , sexual dysfunction , erectile dysfunction , medicine , sexual function , incidence (geometry) , concomitant , bipolar disorder , medical prescription , clinical psychology , psychiatry , pharmacology , physics , optics
Objective Lithium treatment remains an important part of the management of many patients with bipolar disorder, but the incidence of treatment‐emergent sexual dysfunction with lithium is uncertain, and little is known about how it might be managed. Method Systematic computerised literature search of preclinical and clinical studies. Results Thirteen relevant papers were identified. Preclinical studies suggest lithium can reduce testosterone levels and impair nitric oxide mediated relaxation of cavernosal tissue. Clinical reports suggest lithium may reduce sexual thoughts and desire, worsen erectile function and reduce sexual satisfaction. Concomitant benzodiazepine prescription with lithium is associated with an increased risk of sexual dysfunction. Sexual dysfunction during lithium treatment appears significantly associated with a lower level of overall functioning and may reduce compliance. Conclusion The findings of this systematic review reveal the paucity of information about the incidence, associated factors and management of sexual dysfunction with lithium treatment and highlight the need for well‐designed studies in this area. Copyright © 2015 John Wiley & Sons, Ltd.